832111-84-9

Upstream product

• 832111-83-8 acetic acid 2-acetoxymethyl-8-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-4-[1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-6-(tert-butyl-diphenyl-silanyloxy)-1,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl ester 
• 832111-72-5 (1aR,3R,3aR,5S,7S,7aS,7bS)-7-[(S)-2-(tert-Butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-3-[(R)-1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-5-(tert-butyl-diphenyl-silanyloxy)-1a-methyl-decahydro-1-oxa-cyclopropa[a]naphthalene 
• 832111-73-6 (1S,4R,4aR,6S,8S,8aS)-8-[(S)-2-(tert-Butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-4-[(R)-1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-6-(tert-butyl-diphenyl-silanyloxy)-2-methylene-decahydro-naphthalen-1-ol 
• 832111-82-7 acetic acid 8-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-4-[1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-6-(tert-butyl-diphenyl-silanyloxy)-2-chloromethyl-1,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl ester 
• 832111-80-5 Acetic acid (1S,4R,4aR,6S,8S,8aS)-8-[(S)-2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-4-[(R)-1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-6-(tert-butyl-diphenyl-silanyloxy)-2-methylene-decahydro-naphthalen-1-yl ester 
• 832111-81-6 acetic acid 8-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethyl]-4-[1-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-propyl]-6-(tert-butyl-diphenyl-silanyloxy)-3-hydroxy-2-methylene-decahydro-naphthalen-1-yl ester 

Downstream Products

• 832111-85-0 Acetic acid (1S,4S,4aR,6S,8R,8aS)-2-acetoxymethyl-6-(tert-butyl-diphenyl-silanyloxy)-4-((R)-1-formyl-2-methyl-propyl)-8-((S)-1-methyl-2-oxo-ethyl)-1,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl ester 

Relevant academic research and scientific papers

Exploratory studies aimed at a synthesis of vinigrol. 2. Attempts to exploit ring-closing metathesis for construction of the central cyclooctane belt

(Chemical Equation Presented) A program directed to the possible adaptation of ring closing metathesis to a total synthesis of vinigrol is described. With a convenient route to intermediates of general type 3 available from a prior investigation, several